Author:
Zohren F,Czibere A,Bruns I,Fenk R,Schroeder T,Gräf T,Haas R,Kobbe G
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference42 articles.
1. Freund M, Diedrich H, Ganser A, Gramatzki M, Heil G, Heyll A et al. Treatment of relapsed or refractory adult acute lymphocytic leukemia. Cancer 1992; 69: 709–716.
2. Koller CA, Kantarjian HM, Thomas D, O'Brien S, Rios MB, Kornblau S et al. The hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia. Leukemia 1997; 11: 2039–2044.
3. Martino R, Bellido M, Brunet S, Altes A, Sureda A, Guardia R et al. Intensive salvage chemotherapy for primary refractory or first relapsed adult acute lymphoblastic leukemia: results of a prospective trial. Haematologica 1999; 84: 505–510.
4. Thomas DA, Kantarjian H, Smith TL, Koller C, Cortes J, O'Brien S et al. Primary refractory and relapsed adult acute lymphoblastic leukemia: characteristics, treatment results, and prognosis with salvage therapy. Cancer 1999; 86: 1216–1230.
5. Thomas X, Danaila C, Le QH, Sebban C, Troncy J, Charrin C et al. Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: a single institution experience of 378 consecutive patients over a 21-year period. Leukemia 2001; 15: 1811–1822.